Cowen Healthcare Conference March 2020 Forward-Looking Statements These slides contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include those relating to, among other things, Chimerix's ability to develop DSTAT and BCV, including the initiation of a Phase 3 clinical trial for DSTAT; Chimerix's ability to ...

Chimerix, Inc. (NASDAQ:CMRX) Q4 2019 Earnings Conference Call February 25, 2020 8:30 AM ET Company Participants Michelle LaSpaluto - Vice President of Strategic Planning & Investor Relations Mike Sherman - President & Chief Executive Officer Mike Andriole - Chief Business Officer & Chief Financial Officer Garrett Nichols - Chief Medical Officer Conference Call Participants Phil Nadeau - Cowen and Co. Ed White - H.C. Wainwright Operator Good morning ladies and gentlemen and welcome to the Chimerix Fourth Qua ...

February Corporate Update Forward-Looking Statements These slides contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Forward-looking statements include those relating to, among other things, Chimerix's ability to develop DSTAT and BCV, including the initiation of a Phase 3 clinical trial for DSTAT; Chimerix's ability to submit and/o ...